Skip to main content
. 2022 Mar 21;13(6):1871–1881. doi: 10.7150/jca.62454

Table 2.

Clinicopathologic characteristics of HCC patients

Characteristics Median (range) or N/%
Age/years, median (range) 61(17-90)
Age group/n (%)
< 60 years 169 (45.3%)
≥ 60 years 204(54.7%)
Gender/n (%)
Male 252 (67.4%)
Female 122 (32.6%)
Race/n (%)
White 182 (50.0%)
Asian 161 (44.2%)
Black 19 (5.2%)
American Indian 2 (0.6%)
G stage/n (%)
G1 55 (14.9%)
G2 178 (48.2%)
G3 124 (33.6%)
G4 12 (3.3%)
TNM stage/n (%)
I 173 (49.0%)
II 88 (24.9%)
III 86 (24.4%)
IV 6 (1.7%)
T stage/n (%)
T1 182 (49.1%)
T2 95 (25.6%)
T3 81 (21.8%)
T4 13 (3.5%)
Vascular invasion/n (%)
Macrovascular invasion 16 (5.0%)
Microvascular invasion 94 (29.6%)
None 208 (65.4%)

HCC, hepatocellular carcinoma. The case numbers of clinicopathologic characteristics are not available, which including 1 for age, 10 for race, 5 for G stage, 21 for TNM stage, 3 for T stage, and 56 for vascular invasion.